These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 34021731)
1. Cutaneous adverse drug reaction in a dog following firocoxib treatment. Geum M; Ko HY; Na YJ; Kim HJ Vet Med Sci; 2021 Sep; 7(5):1504-1508. PubMed ID: 34021731 [TBL] [Abstract][Full Text] [Related]
2. Clinical effectiveness and safety of a new NSAID, firocoxib: a 1,000 dog study. Ryan WG; Moldave K; Carithers D Vet Ther; 2006; 7(2):119-26. PubMed ID: 16871494 [TBL] [Abstract][Full Text] [Related]
3. Tolerance of firocoxib in dogs with osteoarthritis during 90 days. Lecoindre O; Pepin-Richard C J Vet Pharmacol Ther; 2011 Apr; 34(2):190-2. PubMed ID: 21395612 [No Abstract] [Full Text] [Related]
4. Efficacy and safety of firocoxib in the management of canine osteoarthritis under field conditions. Hanson PD; Brooks KC; Case J; Conzemius M; Gordon W; Schuessler J; Shelley B; Sifferman R; Drag M; Alva R; Bell L; Romano D; Fleishman C Vet Ther; 2006; 7(2):127-40. PubMed ID: 16871495 [TBL] [Abstract][Full Text] [Related]
5. Randomized trial of cisplatin versus firocoxib versus cisplatin/firocoxib in dogs with transitional cell carcinoma of the urinary bladder. Knapp DW; Henry CJ; Widmer WR; Tan KM; Moore GE; Ramos-Vara JA; Lucroy MD; Greenberg CB; Greene SN; Abbo AH; Hanson PD; Alva R; Bonney PL J Vet Intern Med; 2013; 27(1):126-33. PubMed ID: 23205923 [TBL] [Abstract][Full Text] [Related]
6. Vesiculobullous skin reaction temporally related to firocoxib treatment in a white rhinoceros (Ceratotherium simum). Stringer EM; De Voe RS; Linder K; Troan B; McCalla-Martin A; Loomis MR J Zoo Wildl Med; 2012 Mar; 43(1):186-9. PubMed ID: 22448531 [TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and safety of firocoxib in the treatment of dogs with osteoarthritis. Autefage A; Palissier FM; Asimus E; Pepin-Richard C Vet Rec; 2011 Jun; 168(23):617. PubMed ID: 21642297 [TBL] [Abstract][Full Text] [Related]
8. The effects of firocoxib (Previcox) in geriatric dogs over a period of 90 days. Joubert KE J S Afr Vet Assoc; 2009 Sep; 80(3):179-84. PubMed ID: 20169752 [TBL] [Abstract][Full Text] [Related]
9. The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis. Vijarnsorn M; Kwananocha I; Kashemsant N; Jarudecha T; Lekcharoensuk C; Beale B; Peirone B; Lascelles BDX BMC Vet Res; 2019 Oct; 15(1):349. PubMed ID: 31623621 [TBL] [Abstract][Full Text] [Related]
10. Clinical evaluation of firocoxib and carprofen for the treatment of dogs with osteoarthritis. Pollmeier M; Toulemonde C; Fleishman C; Hanson PD Vet Rec; 2006 Oct; 159(17):547-51. PubMed ID: 17056650 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the adverse effects of oral firocoxib in healthy dogs. Steagall PV; Mantovani FB; Ferreira TH; Salcedo ES; Moutinho FQ; Luna SP J Vet Pharmacol Ther; 2007 Jun; 30(3):218-23. PubMed ID: 17472653 [TBL] [Abstract][Full Text] [Related]
12. Assessment of the efficacy of firocoxib (Previcox®) and grapiprant (Galliprant®) in an induced model of acute arthritis in dogs. de Salazar Alcalá AG; Gioda L; Dehman A; Beugnet F BMC Vet Res; 2019 Aug; 15(1):309. PubMed ID: 31464629 [TBL] [Abstract][Full Text] [Related]
13. Transient Fanconi Syndrome After Treatment with Firocoxib, Cefadroxil, Tramadol, and Famotidine in a Maltese. Ahn JO; Kim SM; Song WJ; Ryu MO; Li Q; Chung JY; Youn HY J Am Anim Hosp Assoc; 2019; 55(6):323-327. PubMed ID: 31525093 [No Abstract] [Full Text] [Related]
14. Effects of firocoxib and tepoxalin on healing in a canine gastric mucosal injury model. Goodman L; Torres B; Punke J; Reynolds L; Speas A; Ellis A; Budsberg S J Vet Intern Med; 2009; 23(1):56-62. PubMed ID: 19175721 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of firocoxib, carprofen and vedaprofen in a sodium urate crystal induced synovitis model of arthritis in dogs. Hazewinkel HA; van den Brom WE; Theyse LF; Pollmeier M; Hanson PD Res Vet Sci; 2008 Feb; 84(1):74-9. PubMed ID: 17408711 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and safety of firocoxib after oral administration of repeated consecutive doses to neonatal foals. Hovanessian N; Davis JL; McKenzie HC; Hodgson JL; Hodgson DR; Crisman MV J Vet Pharmacol Ther; 2014 Jun; 37(3):243-51. PubMed ID: 24749691 [TBL] [Abstract][Full Text] [Related]
17. Switching NSAIDs in practice: insights from the Previcox (firocoxib) Experience Trial. Ryan WG; Moldave K; Carithers D Vet Ther; 2007; 8(4):263-71. PubMed ID: 18183545 [TBL] [Abstract][Full Text] [Related]
18. Periovulatory administration of firocoxib did not alter ovulation rates and mitigated post-breeding inflammatory response in mares. Friso AM; Segabinazzi LGTM; Cyrino M; Correal SB; Freitas-Dell'Aqua CP; Teoro do Carmo M; Dell'Aqua JA; Miró J; Papa FO; Alvarenga MA Theriogenology; 2019 Oct; 138():24-30. PubMed ID: 31280182 [TBL] [Abstract][Full Text] [Related]
19. Effects of firocoxib, meloxicam, and tepoxalin on prostanoid and leukotriene production by duodenal mucosa and other tissues of osteoarthritic dogs. Punke JP; Speas AL; Reynolds LR; Budsberg SC Am J Vet Res; 2008 Sep; 69(9):1203-9. PubMed ID: 18764695 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of oral administration of firocoxib for the management of musculoskeletal pain and lameness associated with osteoarthritis in horses. Orsini JA; Ryan WG; Carithers DS; Boston RC Am J Vet Res; 2012 May; 73(5):664-71. PubMed ID: 22533398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]